Portfolio company CellFE Biotech has closed their Series A funding round, securing $22 million in financing

The round was led by M Ventures , with participation from GreatPoint Ventures and Riverine Ventures, as well as existing investors at Cota Capital, Dynamk Capital, Elm Street Ventures, Embark Ventures, EGB Capital, and Khosla Ventures.  The fundraising highlights a landmark year for the CellFE team, having launched their cellular engineering platform, the Infinity MTx™ system, expanded the scientific and commercial teams, and announced the transition to a larger research facility at Blue Rise Ventures Research Park in Alameda, CA.